Watkins Frank T's Form 4 filing
Shockwave Medical, Inc. (SWAV) · filed Apr 21, 2023
- Accession no.
- 0001209191-23-025279
- Filed
- Apr 21, 2023
- Trade date
- Apr 20, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $784.3K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Watkins Frank TCIK 0001305831 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 20, 2023 | Common Stock | MOption exerciseAcquired | +1,491 | $2.20 | +$3,280.2 | 5,287 | Direct | |
| Apr 20, 2023 | Common Stock | MOption exerciseAcquired | +1,509 | $3.42 | +$5,160.78 | 6,796 | Direct | |
| Apr 20, 2023 | Common Stock | SSaleDisposed | −600 | $259.89 | −$155,934 | 6,196 | Direct | |
| Apr 20, 2023 | Common Stock | SSaleDisposed | −1,000 | $261.37 | −$261,370 | 5,196 | Direct | |
| Apr 20, 2023 | Common Stock | SSaleDisposed | −1,400 | $262.13 | −$366,982 | 3,796 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 20, 2023 | Common Stock | MOption exerciseDisposed | −1,491 | $0.00 | $0 | 0 | Direct | |
| Apr 20, 2023 | Common Stock | MOption exerciseDisposed | −1,509 | $0.00 | $0 | 111,313 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.